Test kits
Help choosing
Also in the shop
See inside a real reportPage 1: summary, score and Target PlotLearn
From the Journal
ConditionsSIBO: breath test or stool test?
TestingHow often should you retest your gut microbiome?
ResearchHow much weight the Firmicutes/
How to read a Target PlotCenter to edge, phylum to speciesAbout GutID
Next-generation sequencing made the gut microbiome measurable at scale. GutID is made by Intus Biosciences, a microbiome sequencing company in Meriden, Connecticut.
GS20
The first commercial next-generation sequencing instrument, built at 454 Life Sciences.
Two of the people behind the GS20 went on to design Titan-1. Our clinical team turns what Titan-1 measures into guidance for practice.
The team
Chief Scientific Officer and Co-Founder, Intus Biosciences. Co-inventor of Titan-1™.
At 454 Life Sciences, Mark led global product and project management on the GS20. He leads the team building the scientific case for the technology across 30+ peer-reviewed publications.
Head of Bioinformatics. Co-inventor of Titan-1™.
Dan was Associate Director of Bioinformatics at 454 Life Sciences. He built the classification platform that identifies organisms from the full long read.
Head of Clinical Education and Training.
A scientist and practitioner in the microbiome, nutrigenetics and precision nutrition. Elena uses microbiome results to shape diet and supplement plans.
Why it is different
Titan-1 has three parts: a lysis and extraction step we make in-house, a patented amplicon, and our own classification software.
Titan-1™ is a patented platform, run in an ISO 9001-certified operation. The method is documented and runs the same way on every sample.
Titan-1™ patentedISO 9001The work is published and the interpretation is written down: what each measure means and how much weight it can carry.
The Clinician Guide
Where samples are processed
A CLIA laboratory in the United States processes every sample on the patented Titan-1 platform. GutID is available in the US, the UK and Canada.
Research and technology partners
Funding: NCI SBIR Fast-Track
